CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Salix Pharmaceuticals Inc. v. Lupin Limited

1:12-cv-01104

Overview

Case Number 1:12-cv-01104
Filing Date 2012-09-07
Status Terminated
Termination Date 2014-09-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Lupin Limited NPE (University / Research)

Represented By

12 Attorneys Listed

Tara Mythri Raghavan

Email: traghavan@rmmslegal.com

Kevin P. Burke

Email: kburke@rmmslegal.com

Erin M. Forbes

UNDELIVERABLE EMAIL 2/5/2019

John D. Polivick

UNDELIVERABLE EMAIL 3/8/2022

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

William A. Rakoczy

Email: wrakoczy@rmmslegal.com

Paul J. Molino

Email: paul@rmmslegal.com

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

William Ward

Email: wward@rmmslegal.com

Ryan M. Daniel

Email: rdaniel@rmmslegal.com

Peter J. Curtin

Email: pcurtin@rmmslegal.com

Damon Gupta

Email: dgupta@greengriffith.com

Plaintiff

Dr. Falk Pharma GmbH Operating Company

Represented By

5 Attorneys Listed

Thomas A. Stevens

E.I du Pont de Nemours and Company

Tel: +1 (302) 999-6200

E.I du Pont de Nemours and Company, Chestnut Run Plaza 721/2152

Kristen Healey Cramer

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320
Fax: +1 (302) 777-4224

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Salix Pharmaceuticals Inc. Operating Company

Represented By

12 Attorneys Listed

Thomas A. Stevens

E.I du Pont de Nemours and Company

Tel: +1 (302) 999-6200

E.I du Pont de Nemours and Company, Chestnut Run Plaza 721/2152

Matthew V. Anderson

Email: manderson@rmmslegal.com

John W Cox

Email: john.cox@wbd-us.com

Deanne M. Mazzochi

Email: dmazzochi@rmmslegal.com

Kristen Healey Cramer

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320
Fax: +1 (302) 777-4224

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Tryn T. Stimart

Email: tstimart@gibbonslaw.com

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Thomas F. Poche

Email: tpoche@wcsr.com

Dana C. Mahadeo

Email: dmahadeo@wcsr.com

Carl B. Massey

Email: cmassey@wcsr.com

Counter Claimant

Lupin Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): 🇩🇪 Germany 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8337886
Pellet formulation for the treatment of the intestinal tract
Filed: 2008-09-23
Issued: 2012-12-25
Expired (Term Ended)
Expires: 2018-04-25
US7547451
Pellet formulation for the treatment of the intestinal tract
Filed: 2003-02-07
Issued: 2009-06-16
Expired (Term Ended)
Expires: 2019-06-08
US8496965
Pellet formulation for the treatment of the intenstinal tract
Filed: 2012-08-15
Issued: 2013-07-30
Active (5.7 yrs remaining)
Expires: 2032-08-15
US6551620
Pellet formulation for the treatment of the intestinal tract
Filed: 2001-07-16
Issued: 2003-04-22
Expired (Term Ended)
Expires: 2021-07-16

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

30

Dispositive

0

Granted

2

Denied

0

Pending / Review

25

Motions by Category

Procedural / Extension Motion 16 Claim Construction / Markman Filing 14

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
REDACTED VERSION of 158 MOTION to Amend/Correct 149 Proposed Pretrial Order,, 151 Exhibit to a Document by Dr. Falk Pharma GmbH, Salix Pharmaceuticals Inc.. (At...
Entry #160 • 2014-09-04 Document →
Procedural / Extension Motion Pending / Under Review
REDACTED VERSION of 157 MOTION to Amend/Correct 149 Proposed Pretrial Order,, Unopposed Motion to Submit a Revised Version of Lupin's Proposed Findings of Fact ...
Entry #159 • 2014-09-03 Document →
Procedural / Extension Motion Pending
Order on Motion to Amend/Correct
Entry #— • 2014-08-29
Procedural / Extension Motion Pending / Under Review
[SEALED] MOTION to Amend/Correct 149 Proposed Pretrial Order,, 151 Exhibit to a Document - filed by Dr. Falk Pharma GmbH, Salix Pharmaceuticals Inc.. (Attachmen...
Entry #158 • 2014-08-28 Document →
Procedural / Extension Motion Pending / Under Review
[SEALED] MOTION to Amend/Correct 149 Proposed Pretrial Order,, Unopposed Motion to Submit a Revised Version of Lupin's Proposed Findings of Fact and Conclusions...
Entry #157 • 2014-08-27 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Serve Opening Expert Reports, Rebuttal Expert Reports and Reply Expert Reports to February 27, 2014, March 27, 2014, and April 17,...
Entry #126 • 2014-02-13 Document →

Docket Entries

(214 total)
Pleading / Complaint

COMPLAINT filed against Lupin Limited, Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1134693.) - filed by Salix Pharmaceuticals Inc., Dr. Falk Pharma GmbH. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(eam) (Entered: 09/07/2012)

Entry #1 • 2012-09-07
1
Pleading / Complaint

COMPLAINT filed against Lupin Limited, Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1134693.) - filed by Salix Pharmaceuticals Inc., Dr. Falk Pharma GmbH. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(eam) (Entered: 09/07/2012)

Entry #1 • 2012-09-07
2
Pleading / Complaint

COMPLAINT filed against Lupin Limited, Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1134693.) - filed by Salix Pharmaceuticals Inc., Dr. Falk Pharma GmbH. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(eam) (Entered: 09/07/2012)

Entry #1 • 2012-09-07
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (eam) (Entered: 09/07/2012)

Entry #2 • 2012-09-07
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) U.S. 6,551,620. (eam) (Entered: 09/07/2012)

Entry #3 • 2012-09-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc